Kosaku Kurata

Kosaku Kurata

Auto-generated profile, based on publicly available information

Kosaku Kurata

Department of Mechanical Engineering, Kyushu University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2016 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
YAY. Asano
Y. Asano
Shinichiro  KashiwagiShinichiro Kashiwagi
Shinichiro Kashiwagi
WGW. Goto
W. Goto
KKK. Kurata
K. Kurata
SNS. Noda
S. Noda
KHK. Hirakawa
K. Hirakawa
Background Tumour‐infiltrating lymphocytes (TILs) can be used to monitor the immune response, and are important in predicting treatment responses and outcomes for various types of cancer. Recently, specific TIL subsets have been reported to be clinically useful in predicting treatment responses. The CD8+/FOXP3+ TIL ratio (CFR) may be a more sensitive indicator for monitoring immune function. This study investigated the clinical significance and value of CFR as a biomarker to predict treatment responses to neoadjuvant chemotherapy for breast cancer. Methods Patients with resectable early‐stage breast cancer treated with neoadjuvant chemotherapy at Osaka City University Hospital, Japan, between 2007 and 2013 were included. Oestrogen receptor, progesterone receptor, human epidermal growth factor receptor (HER) 2, Ki‐67, CD8 and FOXP3 status were assessed by immunohistochemistry, and correlated with pathological complete response (pCR). Results A total of 177 patients were included, of whom 90 had a high CFR and 87 a low CFR. Triple‐negative breast cancer (TNBC) was more common in the high‐CFR group than in the low‐CFR group (46 versus 23 per cent; P = 0·002), as was HER2‐enriched breast cancer (HER2BC) (27 versus 14 per cent; P = 0·033). Among these patients, the pCR rate was significantly higher in the high‐CFR group than in the low‐CFR group (TNBC: P = 0·022; HER2BC: P < 0·001). In multivariable analysis high‐CFR status was an independent predictor of a favourable prognosis: hazard ratio 0·24 (95 per cent c.i. 0·05 to 0·72; P = 0·015) for TNBC and 0·10 (0·10 to 0·90; P = 0·041) for HER2BC. Conclusion The CFR may be a useful biomarker to predict treatment response to neoadjuvant therapy in aggressive breast cancer subtypes, such as TNBC and HER2BC.

23 May 2017 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
KKKosaku Kurata
Kosaku Kurata
JMJunpei Matsushita
Junpei Matsushita
AFAtsushi Furuno
Atsushi Furuno
JFJunichi Fujino
Junichi Fujino
HTHiroshi Takamatsu
Hiroshi Takamatsu

1 May 2014 in International Journal of Heat and Mass Transfer
Verified
Journal Article
Closed access
KKKosaku Kurata
Kosaku Kurata
SNSeiji Nomura
Seiji Nomura
HTHiroshi Takamatsu
Hiroshi Takamatsu

1 April 2016 in International Journal of Heat and Mass Transfer
Verified
Journal Article
Closed access
KNKazuhiro Nishimura
Kazuhiro Nishimura
Haidong WangHaidong Wang
Haidong Wang
TFTakanobu Fukunaga
Takanobu Fukunaga
KKKosaku Kurata
Kosaku Kurata
HTHiroshi Takamatsu
Hiroshi Takamatsu

28 December 2020 in HardwareX
Verified
Journal Article
Open access
KKKosaku Kurata
Kosaku Kurata
• Open-source colorimeter that can be fabricated easily and inexpensively by using items available in online shops. • No drilling, screw thread cutting, gluing, or soldering of electronic components is required. • Three different wavelengths of incident light with peaks at 460 nm (blue), 515 nm (green), and 630 nm (red) can be selected. • Well-designed durable enclosure for improving repeatability and accuracy of measurements.

1 January 2007 in Journal of Biomechanical Science and Engineering
Verified
Journal Article
Open access
GGGuoliang Gu
Guoliang Gu
KKKosaku Kurata
Kosaku Kurata
ZCZhi Jane Chen
Zhi Jane Chen
KVKalervo H. Väänänen
Kalervo H. Väänänen